ISPC vs MTD · rev $9.3M vs P/E 27, rev $3.87B
iSpecimen Inc (ISPC) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
ISPC currently screens at market cap $4.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the ISPC and MTD stock pages for the full models.
Not investment advice.